Commentary on the First-Line Support for Assistance in Breathing in Children Trials on Noninvasive Respiratory Support: Taking a Closer Look
Related Experiment Video
Updated: Aug 23, 2025

Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
Padmanabhan Ramnarayan1,2, Mark J Peters3,4
1Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.
Insights
High-flow nasal cannula (HFNC) and continuous positive airway pressure (CPAP) are key noninvasive respiratory support methods. The FIRST-ABC trials provide crucial data comparing their effectiveness in critically ill children, guiding clinical practice.
Area of Science:
- Pediatric Critical Care Medicine
- Respiratory Physiology
- Clinical Trials Methodology
Background:
- Noninvasive respiratory support, including high-flow nasal cannula (HFNC) and continuous positive airway pressure (CPAP), is vital for managing respiratory failure in critically ill children.
- Previous research comparing HFNC and CPAP efficacy in pediatric populations was limited by small sample sizes and observational designs.
- The FIRST-ABC trials were initiated to address the evidence gap regarding these widely used noninvasive ventilation strategies.
Purpose of the Study:
- To compare the efficacy of HFNC and CPAP in critically ill children requiring noninvasive respiratory support.
- To evaluate the impact of these modalities on time to liberation from respiratory support in both acutely ill and post-extubation pediatric patients.
- To provide high-quality evidence to standardize clinical practice in pediatric noninvasive respiratory support.
Main Methods:
- The First-Line Support for Assistance in Breathing in Children (FIRST-ABC) trials included two pragmatic randomized clinical trials (RCTs): a step-up RCT for acutely ill children and a step-down RCT for extubated children.
- A total of 1200 critically ill children were randomized to receive either HFNC or CPAP.
- The primary outcome measured was the time to liberation from all forms of respiratory support, excluding supplemental oxygen.
Main Results:
- The FIRST-ABC trials provide the first large-scale RCT data comparing HFNC and CPAP in a mixed group of critically ill children.
- Results from these trials offer significant insights into the comparative effectiveness of these two noninvasive respiratory support modalities.
- The findings are expected to influence clinical decision-making and reduce practice variability in pediatric respiratory care.
Conclusions:
- The FIRST-ABC trials represent a major advancement in the evidence base for noninvasive respiratory support in pediatric critical care.
- The trial findings have direct implications for clinical practice, potentially altering the standard of care for respiratory support in children.
- This research addresses a long-standing need for robust comparative data on HFNC versus CPAP in pediatric patients.
Abstract:
Noninvasive respiratory support modalities such as high-flow nasal cannula (HFNC) therapy and continuous positive airway pressure (CPAP) are used frequently in pediatric critical care to support acutely ill children with respiratory failure (step-up management) and children following extubation (step-down management). Although there are several observational studies and database analyses comparing the efficacy of HFNC and CPAP, and a few small randomized clinical trials (RCTs), until recently, there were no large RCTs comparing the two modalities in a mixed group of critically ill children. In the first half of 2022, results from the First-Line Support for Assistance in Breathing in Children (FIRST-ABC) trials were published; these comprised a master protocol of two trials: one in acutely ill children (step-up RCT) and one in extubated children (step-down RCT). Each of these pragmatic trials randomized 600 children to either HFNC or CPAP when the treating clinician decided that noninvasive respiratory support beyond standard oxygen therapy was required. The primary outcome was time to liberation from all forms of respiratory support (invasive and noninvasive), excluding supplemental oxygen. The FIRST-ABC trials represent a significant advance in the field of noninvasive respiratory support, which has traditionally been evidence-poor and associated with considerable variability in clinical practice. In this article, we provide an overview of how the FIRST-ABC trials were conceived and conducted, our view on the results, and how the trial findings have changed our clinical practice.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

